A cost model for complications in diabetes type II patients
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: HARTZEMA, Abraham (University of Florida, Gainesville, United States of America)
- Co-author(s): Winterstein, Almut (University of Florida, Gainesville, United States of America)
Segal, Rich (University of Florida, Gainesville, United States of America)
Snedecor, Sonya (Pharmetrics, Washington, United States of America)
Diabetes mellitus, a disease increasing in prevalence, if left uncontrolled leads to debilitating complications, including renal failure and blindness. Glycosylated hemoglobin (HbA1c), an indicator of glycemic control over a 3-month time period, is the preferred measure for determining whether a diabetic is controlled. The level of glycemic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.